These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1361175)

  • 1. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Skoumas JN; Paleologos AA; Toutouzas PK
    Eur Heart J; 1992 Nov; 13(11):1506-13. PubMed ID: 1361175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Toutouza MA; Paleologos AA; Toutouzas PK
    Am J Cardiol; 1991 May; 67(11):987-92. PubMed ID: 1673284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins.
    Weidmann P; Bianchetti MG; Mordasini R
    Curr Med Res Opin; 1983; 8 Suppl 3():123-34. PubMed ID: 6137325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
    Fogari R; Zoppi A; Corradi L; Preti P; Mugellini A; Lusardi P
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
    Houston MC; Burger C; Hays JT; Nadeau J; Swift L; Bradley CA; Olafsson L
    Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
    Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H; Stradner F
    Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
    Harvengt C; Heller FR; Martiat P; Van Nieuwenhuyze Y
    J Clin Pharmacol; 1987 Jul; 27(7):475-80. PubMed ID: 2888790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN; Brownlee WC; Large DM
    Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
    Fogari R; Zoppi A; Tettamanti F; Malamani G; Pasotti C
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
    Sasaki J; Koga S; Uzawa H; Arakawa K
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
    Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.
    Bielmann P; Brun D; Gagné C; Morrjani S; Jéquier JC; Bertrand M; Lupien PJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):259-64. PubMed ID: 6125482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.